IRIS
PIETROLUONGO, ERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.246
NA - Nord America 1.115
EU - Europa 781
SA - Sud America 113
Continente sconosciuto - Info sul continente non disponibili 51
AF - Africa 23
OC - Oceania 1
Totale 3.330
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.059
SG - Singapore 481
RU - Federazione Russa 307
CN - Cina 265
IT - Italia 239
VN - Vietnam 227
HK - Hong Kong 79
BR - Brasile 77
DE - Germania 71
BD - Bangladesh 56
FR - Francia 44
CA - Canada 40
IN - India 35
FI - Finlandia 31
GB - Regno Unito 27
JP - Giappone 26
KR - Corea 18
NL - Olanda 18
AR - Argentina 14
CI - Costa d'Avorio 10
PL - Polonia 9
PH - Filippine 8
ZA - Sudafrica 7
IQ - Iraq 6
MX - Messico 6
TH - Thailandia 6
TW - Taiwan 6
CL - Cile 5
ES - Italia 5
RS - Serbia 5
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
CO - Colombia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
EG - Egitto 3
ID - Indonesia 3
IE - Irlanda 3
JM - Giamaica 3
PK - Pakistan 3
SY - Repubblica araba siriana 3
UA - Ucraina 3
UY - Uruguay 3
UZ - Uzbekistan 3
EC - Ecuador 2
KH - Cambogia 2
KZ - Kazakistan 2
LT - Lituania 2
PE - Perù 2
PY - Paraguay 2
SE - Svezia 2
TR - Turchia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
CY - Cipro 1
DZ - Algeria 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
NG - Nigeria 1
NP - Nepal 1
PS - Palestinian Territory 1
RO - Romania 1
SA - Arabia Saudita 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 3.280
Salva come PNG Salva come JPEG
Città #
San Jose 296
Singapore 258
Hefei 110
Ashburn 92
Hong Kong 72
Naples 69
Moscow 68
Ho Chi Minh City 63
Council Bluffs 60
Hanoi 52
Beijing 51
Santa Clara 47
Los Angeles 40
Munich 34
New York 34
Dallas 30
Chandler 27
Lauterbourg 25
Tokyo 24
Milan 23
The Dalles 20
Buffalo 18
Kochi 17
Rome 17
Seoul 16
Toronto 15
Turku 15
Lappeenranta 14
Haiphong 13
Casoria 12
Boston 11
Denver 11
Frankfurt am Main 11
Amsterdam 10
Da Nang 10
Montreal 10
Orem 9
São Paulo 8
Nuremberg 7
Biên Hòa 6
Millbury 6
Warsaw 6
Belo Horizonte 5
Brooklyn 5
Chennai 5
Phoenix 5
Poplar 5
Charlotte 4
Johannesburg 4
Lawrence 4
London 4
Manchester 4
Portici 4
Redondo Beach 4
Turin 4
Veroli 4
Washington 4
Atlanta 3
Baghdad 3
Belgrade 3
Boardman 3
Chiaravalle Centrale 3
Des Moines 3
Düsseldorf 3
Falkenstein 3
Frisco 3
Houston 3
Kingston 3
Mexico City 3
Miami 3
Montevideo 3
Ottawa 3
Pagani 3
Philadelphia 3
Porto Alegre 3
Pune 3
San Antonio 3
San José 3
Santiago 3
Seattle 3
Vienna 3
Afragola 2
Almaty 2
Augusta 2
Bexley 2
Bologna 2
Boydton 2
Brasília 2
Brno 2
Bắc Giang 2
Bến Tre 2
Cairo 2
Can Tho 2
Cebu City 2
Chicago 2
Columbus 2
Córdoba 2
Damascus 2
Dubai 2
Dublin 2
Totale 1.912
Salva come PNG Salva come JPEG
Nome #
Shifting from a Biological-Agnostic Approach to a Molecular-Driven Strategy in Rare Cancers: Ewing Sarcoma Archetype 210
Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors 207
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: A survey of young oncologists 197
DLL3 as a potential diagnostic and therapeutic target in neuroendocrine neoplasms: A narrative review 172
The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug? 165
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671) 164
Serum biomarkers of inflammation and vascular damage upon SARS-Cov-2 mRNA vaccine in patients with thymic epithelial tumors 163
Extraskeletal Ewing's sarcoma of the mediastinum: Case report 162
Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era 154
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide 152
Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational study 149
COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study 144
Exploring the interplay between Kaposi's sarcoma and SARS‐CoV‐2 infection: A case series and systematic review 140
BRAF Gene and Melanoma: Back to the Future 137
Immunological signature of patients with thymic epithelial tumors and Good syndrome 123
Case report: Potential role of immunotherapy in thymic malignancies: a unique case of a durable and complete response upon an immune checkpoint inhibitor 119
Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response 116
miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer 112
The Role of GLP-1 Agonists in Mitigating Lorlatinib-Induced Metabolic Syndrome: Two Case Studies 73
Glucocorticoid Receptor and Ovarian Cancer: From Biology to Therapeutic Intervention 72
Insights on the association of anthropometric and metabolic variables with tumor features and genomic risk in luminal early breast cancer: Results of a multicentric prospective study 69
Diagnosis and treatment of paragangliomas and pheochromocytomas: a survey from the Italian Association for Neuroendocrine Tumors 65
The European Reference Network: the keystone for the management of rare thoracic cancers 57
Management of Autoimmune Conditions Associated With Thymic Epithelial Tumors 51
When rarity meets thoracic cancers: a narrative review from ITMIG 2024 49
Multidisciplinary approach for rare thoracic tumors during COVID-19 pandemic 44
Circulating innate lymphoid cells and IL-18 as potential immune biomarkers in thymic tumors 23
Serum HDL subfractions are impaired by COVID-19 vaccine in patients with thymic epithelial tumors 22
Impact of relative dose intensity of first-line platinum-based chemotherapy in patients with thymic epithelial tumors: a retrospective study 15
Immune-related disorders in patients with Thymic Epithelial Tumors: from pathogenesis to tailored interventions 2
null 2
Totale 3.330
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.836
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202229 0 0 1 0 1 2 0 2 0 3 9 11
2022/202381 3 7 1 5 8 8 0 6 15 19 4 5
2023/2024130 5 16 25 17 9 7 2 20 2 1 18 8
2024/2025794 16 30 3 39 28 42 89 45 38 85 316 63
2025/20262.043 158 141 184 152 312 134 298 117 213 151 72 111
2026/2027225 71 97 57 0 0 0 0 0 0 0 0 0
Totale 3.330